SINOTHERAPEUTICS subsidiary Xuantai Pharmaceutical has passed the EU GMP certification

SINOTHERAPEUTICS's wholly-owned subsidiary, Jiangsu SINOTHERAPEUTICS Pharmaceutical Co., Ltd., recently received GMP certification from the European Medicines Agency (EMA). This is another significant achievement following its certifications from multiple national drug regulatory authorities, including China's NMPA, the U.S. FDA, Japan's PMDA, and Saudi Arabia's SFDA. It signifies that the company's quality system is aligned with international standards, helping to expand overseas markets, enhance market competitiveness, and support the company in providing R&D and production services to global pharmaceutical and biotechnology companies